Monoclonal antibody specific for IDH1 R132H mutation.
IDH1 R132H mutations occur in approximately 70% of astrocytomas and oligodendroglial tumors. We developed a mouse monoclonal antibody targeting the IDH1 R132H mutation. Here, we show the high specificity and sensitivity of this antibody on Western blots and tissue sections from formalin fixed paraffin embedded tumor specimens. This antibody is highly useful for tumor classification, in detecting single infiltrating tumor cells and for the characterization of the cellular role of mutant IDH1 protein.
Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University Heidelberg, Im Neuenheimer Feld 220/221, 69120 Heidelberg, Germany.
David
D
Capper
Hanswalter
H
Zentgraf
Jörg
J
Balss
Christian
C
Hartmann
Andreas
A
von Deimling
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000378:metabolism*; D001120:Arginine / Q000235:genetics; D001254:Astrocytoma / Q000378:metabolism; D001932:Brain Neoplasms / Q000378:metabolism; D006639:Histidine / Q000235:genetics; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000235:genetics* / Q000276:immunology; D051379:Mice; D050505:Mutant Proteins / Q000235:genetics / Q000276:immunology*; D009154:Mutation / Q000235:genetics* / Q000276:immunology; D009837:Oligodendroglioma / Q000378:metabolism; D012680:Sensitivity and Specificity
D000911:Antibodies, Monoclonal; D050505:Mutant Proteins; D006639:Histidine; D001120:Arginine; D007521:Isocitrate Dehydrogenase; C543588:IDH1 protein, human